The complexity of the eye provides unique challenges to ocular drug delivery strategies. Pharmaceutical interventions and drug delivery methods for treating eye diseases and disorders vary considerably depending on the nature and extent of the disease or disorder. The anatomy, physiology, and biochemistry of the eye render this organ highly impervious to foreign substances. Conventional systems like eye drops, suspensions, and ointments are not considered optimal in the treatment of vision-threatening ocular diseases.
At SPARC, we are focusing on developing non-invasive formulations for both anterior and posterior segment eye disorders, with an aim of designing a therapeutic system to achieve optimal concentration of a drug at the active site for the appropriate duration.